SSR-182289A (Free) is a thrombin inhibitor potentially for the treatment of thrombosis. SSR-182289A had been in phase II clinical trials by Sanofi for the treatment of thrombosis. But, this research was discontinued in 2009. References: A role for thrombin in liver fibrosis J Gillibert Duplantier, L Dubuisson, N Senant, G Freyburger, I Laurendeau, J-M Herbert, A Desmoulière, J Rosenbaum Gut. 2004 Nov; 53(11): 1682–1687. doi: 10.1136/gut.2003.032136 PMCID: PMC1774287

纯度：≥98%

CAS：363151-21-7